AKT1 and cancer: Supporting our data, overexpression of miR-181a also enhanced cell proliferation through increased glycolysis via affecting the PTEN/AKT pathway in CRC cells.24 However, contrary to our data, miR-181c inhibited glycolysis by targeting hexokinase 2 in cancer-associated fibroblasts.25